Publications by authors named "Azucena Pajares"
Article Synopsis
- Tracheal intubations in the ICU face challenges like poor glottic view and higher complication rates; this study compares the efficacy of two videolaryngoscope (VL) types: the standard Macintosh blade versus a hyperangulated blade.
- The INtubation VIdeolaryngoscopy BLADE-ICU trial is a randomized, controlled study conducted across 29 ICUs in Spain, focusing on first-attempt intubation success as the primary outcome, along with other measures like time to intubation and complication rates.
- The study has ethical approval and aims to improve airway management outcomes, with patient enrollment starting in May 2024 and anticipated results to be published in 2025.
Objective: To quantify the acute effects of dobutamine in postoperative low cardiac output syndrome (LCOS) using transthoracic echocardiographic, hemodynamic, and blood biomarker monitoring and to assess its association with clinical outcomes.
Design: Observational prospective study.
Setting: Single university hospital.
Use of Dexmedetomidine in Cardiothoracic and Vascular Anesthesia.
J Cardiothorac Vasc Anesth
June 2018
Dexmedetomidine is a highly selective α-adrenergic agonist with analgesic and sedative properties. In the United States, the Food and Drug Administration approved the use of the drug for short-lasting sedation (24 h) in intensive care units (ICUs) in patients undergoing mechanical ventilation and endotracheal intubation. In October 2008, the Food and Drug Administration extended use of the drug for the sedation of nonintubated patients before and during surgical and nonsurgical procedures.
View Article and Find Full Text PDFObjective: To study the impact on postoperative costs of a patient's antithrombin levels associated with outcomes after cardiac surgery with extracorporeal circulation.
Design: An analytic decision model was designed to estimate costs and clinical outcomes after cardiac surgery in a typical patient with low antithrombin levels (<63.7%) compared with a patient with normal antithrombin levels (≥63.